Cargando…
Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters
Oral delivery of an inexpensive COVID-19 (coronavirus disease 2019) vaccine could dramatically improve immunization rates, especially in low- and middle-income countries. Previously, we described a potential universal COVID-19 vaccine, rLVS ΔcapB/MN, comprising a replicating bacterial vector, LVS (l...
Autores principales: | Jia, Qingmei, Bielefeldt-Ohmann, Helle, Maison, Rachel M., Hartwig, Airn, Masleša-Galić, Saša, Bowen, Richard A., Horwitz, Marcus A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100875/ https://www.ncbi.nlm.nih.gov/pubmed/36916971 http://dx.doi.org/10.1128/spectrum.05035-22 |
Ejemplares similares
-
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters
por: Jia, Qingmei, et al.
Publicado: (2021) -
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge
por: Jia, Qingmei, et al.
Publicado: (2022) -
Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice
por: Jia, Qingmei, et al.
Publicado: (2022) -
Activity of Galidesivir in a Hamster Model of SARS-CoV-2
por: Taylor, Ray, et al.
Publicado: (2021) -
Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia
por: Jia, Qingmei, et al.
Publicado: (2018)